SCHEMBL8635564

SCHEMBL8635564

O=C1OC(CO)CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9140746 1.00
SCHEMBL10100221 1.00
SCHEMBL25959621 0.83 ALDH1A1 (0.33)
SCHEMBL18702567 0.80 LMNA (0.36)
SCHEMBL10120770 0.80
SCHEMBL2959559 0.80
SCHEMBL6933816 0.78 LMNA (0.44)
SCHEMBL15895449 0.78 LMNA (0.44)
SCHEMBL20707209 0.78 LMNA (0.44)
SCHEMBL22628561 0.78 LMNA (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0534907-B1 The use of furanone derivatives for the prevention or treatment of autoimmune diseases NIPPON ZOKI PHARMACEUTICAL CO (JP) 1998-08-05 EP claimed
US-5532271-A TREATMENT OF RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, ENCEPHALOMYELITIS, HEMOLYTIC ANEMIA NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US claimed
US-5376682-A Autoimmune diseases NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1994-12-27 US claimed
EP-0534907-A1 The use of furanone derivatives for the prevention or treatment of autoimmune diseases NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1993-03-31 EP claimed
EP-0534907-B1 The use of furanone derivatives for the prevention or treatment of autoimmune diseases NIPPON ZOKI PHARMACEUTICAL CO (JP) 1998-08-05 EP disclosed
EP-0534907-A1 The use of furanone derivatives for the prevention or treatment of autoimmune diseases NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1993-03-31 EP disclosed